Odyssey Health, Inc. Strengthens Balance Sheet with $8.7 Million in Net Equity [Yahoo! Finance]
Oragenics Inc. (OGEN)
NASDAQ:AMEX Investor Relations:
ir.oragenics.com
Company Research
Source: Yahoo! Finance
company focused on developing unique, life-enhancing medical products, recently filed its quarterly report for the quarter ended January 31, 2024. The Company reported $13.2 million in net income attributable to stockholders and total stockholder equity of $8.7 million. The increase in net positive equity is due to the sale of its neurological assets to Oragenics, Inc. on December 28, 2023. As part of the consideration for the assets, the Company received eight million shares of Oragenics Series F preferred stock and converted 511,308 into common stock. The Oragenics stock is recorded as an investment on the Company's balance sheet. "We are pleased that we have executed our strategy of acquiring assets, developing them further to create value, then partnering or selling them where we can monetize the value. Odyssey Health is committed to continued growth, capitalizing on the $13 million of income we realized this quarter, we will continue to develop our current portfolio and look to
Show less
Read more
Impact Snapshot
Event Time:
OGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OGEN alerts
High impacting Oragenics Inc. news events
Weekly update
A roundup of the hottest topics
OGEN
News
- Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Oragenics, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards [Yahoo! Finance]Yahoo! Finance
- Oragenics, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing StandardsBusiness Wire
- Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Oragenics, Inc. Files 10K and Provides Company Update [Yahoo! Finance]Yahoo! Finance
OGEN
Sec Filings
- 4/22/24 - Form 8-K
- 4/16/24 - Form 8-K
- 3/29/24 - Form 10-K
- OGEN's page on the SEC website